Lunai Bioworks Inc. (RENB)
(Delayed Data from NSDQ)
$0.14 USD
-0.03 (-18.54%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $0.14 0.00 (-0.43%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Lunai Bioworks Inc. has a market cap of $29.71M, which represents its share price of $0.17 multiplied by its outstanding shares number of 172.12M. As a small-cap company, RENB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RENB 0.14 -0.03(-18.54%)
Will RENB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RENB based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RENB
12 Health Care Stocks Moving In Thursday's Intraday Session
Lunai Bioworks (RENB) Enhances Parkinson's Research Program
Lunai Bioworks advances biomarker discovery preclinical program in Parkinson’s
Lunai Bioworks advances biomarker discovery preclinical program in Parkinson's
Is RENB building pressure? NR7 shows up after soaring 5.63%